The SURMOUNT-1 trial found that participants without diabetes who took the highest dose of tirzepatide lost an average of 22.5% of body weight over 72 weeks, more than triple what most pre-GLP-1 interventions achieved
Rabiolo A, Fantaguzzi F, Montesano G, Brambati M, Sacconi R, Gelormini F et al
Results: 27 Donor Recovery Facilities, 121 Transplant Centers, and 4,353 Donor Hospitals were initially geocoded
That includes drinking less as well as opting for lower-calorie alcoholic beverages such as skinny drinks containing less syrup and sugar versus traditional high-calorie cocktails or sugar-laden mocktails, the report said
You might start with drops and want to transition to injections for stronger effects
in June 2024